Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

A tessellation-based colocalization analysis approach for single-molecule localization microscopy.

Levet F, Julien G, Galland R, Butler C, Beghin A, Chazeau A, Hoess P, Ries J, Giannone G, Sibarita JB.

Nat Commun. 2019 May 30;10(1):2379. doi: 10.1038/s41467-019-10007-4.

2.

Molecular dynamics of starch and water during bread making monitored with temperature-controlled time domain 1H NMR.

Nivelle MA, Beghin AS, Bosmans GM, Delcour JA.

Food Res Int. 2019 May;119:675-682. doi: 10.1016/j.foodres.2018.10.045. Epub 2018 Oct 13.

PMID:
30884703
3.

Maternal T-cell engraftment impedes with diagnosis of a SCID-ADA patient.

Lanfranchi A, Lougaris V, Notarangelo LD, Soncini E, Comini M, Beghin A, Bolda F, Montanelli A, Imberti L, Porta F.

Clin Immunol. 2018 Aug;193:118-120. doi: 10.1016/j.clim.2018.01.004. Epub 2018 May 7.

PMID:
29355610
4.

Chronic Granulomatous Disease in children: a single center experience.

Beghin A, Comini M, Soresina A, Imberti L, Zucchi M, Plebani A, Montanelli A, Porta F, Lanfranchi A.

Clin Immunol. 2018 Mar;188:12-19. doi: 10.1016/j.clim.2017.11.016. Epub 2017 Dec 7.

PMID:
29223406
5.

Localization-based super-resolution imaging meets high-content screening.

Beghin A, Kechkar A, Butler C, Levet F, Cabillic M, Rossier O, Giannone G, Galland R, Choquet D, Sibarita JB.

Nat Methods. 2017 Dec;14(12):1184-1190. doi: 10.1038/nmeth.4486. Epub 2017 Oct 30.

PMID:
29083400
6.

Partial depletion of TCR alpha/beta(+)/ CD19(+) cells in matched unrelated transplantation of three patients with osteopetrosis.

Porta F, Cavagnini S, Imberti L, Sottini A, Bolda F, Beghin A, Caruso A, Lanfranchi A.

Bone Marrow Transplant. 2015 Dec;50(12):1583-5. doi: 10.1038/bmt.2015.201. Epub 2015 Sep 14. No abstract available.

PMID:
26367231
7.

SR-Tesseler: a method to segment and quantify localization-based super-resolution microscopy data.

Levet F, Hosy E, Kechkar A, Butler C, Beghin A, Choquet D, Sibarita JB.

Nat Methods. 2015 Nov;12(11):1065-71. doi: 10.1038/nmeth.3579. Epub 2015 Sep 7.

PMID:
26344046
8.

Automated immunohistochemical method to quantify neuronal density in brain sections: application to neuronal loss after status epilepticus.

Woeffler-Maucler C, Beghin A, Ressnikoff D, Bezin L, Marinesco S.

J Neurosci Methods. 2014 Mar 30;225:32-41. doi: 10.1016/j.jneumeth.2014.01.009. Epub 2014 Jan 23.

PMID:
24462622
9.

MicroRNA-34b promoter hypermethylation induces CREB overexpression and contributes to myeloid transformation.

Pigazzi M, Manara E, Bresolin S, Tregnago C, Beghin A, Baron E, Giarin E, Cho EC, Masetti R, Rao DS, Sakamoto KM, Basso G.

Haematologica. 2013 Apr;98(4):602-10. doi: 10.3324/haematol.2012.070664. Epub 2012 Oct 25.

10.

Pharmacological inhibition of LIM kinase stabilizes microtubules and inhibits neoplastic growth.

Prudent R, Vassal-Stermann E, Nguyen CH, Pillet C, Martinez A, Prunier C, Barette C, Soleilhac E, Filhol O, Beghin A, Valdameri G, Honoré S, Aci-Sèche S, Grierson D, Antonipillai J, Li R, Di Pietro A, Dumontet C, Braguer D, Florent JC, Knapp S, Bernard O, Lafanechère L.

Cancer Res. 2012 Sep 1;72(17):4429-39. Epub 2012 Jul 3.

11.

Presence of high-ERG expression is an independent unfavorable prognostic marker in MLL-rearranged childhood myeloid leukemia.

Pigazzi M, Masetti R, Martinolli F, Manara E, Beghin A, Rondelli R, Locatelli F, Fagioli F, Pession A, Basso G.

Blood. 2012 Jan 26;119(4):1086-7; author reply 1087-8. doi: 10.1182/blood-2011-10-385815. No abstract available.

PMID:
22282493
12.

MLL partner genes drive distinct gene expression profiles and genomic alterations in pediatric acute myeloid leukemia: an AIEOP study.

Pigazzi M, Masetti R, Bresolin S, Beghin A, Di Meglio A, Gelain S, Trentin L, Baron E, Giordan M, Zangrando A, Buldini B, Leszl A, Putti MC, Rizzari C, Locatelli F, Pession A, Te Kronnie G, Basso G.

Leukemia. 2011 Mar;25(3):560-3. doi: 10.1038/leu.2010.316. Epub 2011 Feb 18. No abstract available.

PMID:
21331072
13.

ICER evokes Dusp1-p38 pathway enhancing chemotherapy sensitivity in myeloid leukemia.

Pigazzi M, Manara E, Beghin A, Baron E, Tregnago C, Basso G.

Clin Cancer Res. 2011 Feb 15;17(4):742-52. doi: 10.1158/1078-0432.CCR-10-0886.

14.

Improved visualization and quantitative analysis of drug effects using micropatterned cells.

Degot S, Auzan M, Chapuis V, Béghin A, Chadeyras A, Nelep C, Calvo-Muñoz ML, Young J, Chatelain F, Fuchs A.

J Vis Exp. 2010 Dec 2;(46). pii: 2514. doi: 10.3791/2514.

15.

High-resolution tomographic diffractive microscopy of biological samples.

Simon B, Debailleul M, Beghin A, Tourneur Y, Haeberlé O.

J Biophotonics. 2010 Jul;3(7):462-7. doi: 10.1002/jbio.200900094.

PMID:
20209580
16.

ADP ribosylation factor like 2 (Arl2) regulates breast tumor aggressivity in immunodeficient mice.

Beghin A, Belin S, Hage-Sleiman R, Brunet Manquat S, Goddard S, Tabone E, Jordheim LP, Treilleux I, Poupon MF, Diaz JJ, Dumontet C.

PLoS One. 2009 Oct 15;4(10):e7478. doi: 10.1371/journal.pone.0007478. Erratum in: PLoS One. 2009;4(11):10.1371/annotation/b0d43779-c9aa-44fe-a46d-71d7d2bc4a6a. Hage Sleiman, Rouba [corrected to Hage-Sleiman, Rouba].

17.

Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells.

Belin S, Beghin A, Solano-Gonzàlez E, Bezin L, Brunet-Manquat S, Textoris J, Prats AC, Mertani HC, Dumontet C, Diaz JJ.

PLoS One. 2009 Sep 25;4(9):e7147. doi: 10.1371/journal.pone.0007147.

18.

Expression of Arl2 is associated with p53 localization and chemosensitivity in a breast cancer cell line.

Béghin A, Matera EL, Brunet-Manquat S, Dumontet C.

Cell Cycle. 2008 Oct;7(19):3074-82. Epub 2008 Oct 12.

PMID:
18818514
19.

Tubulin folding pathways: implication in the regulation of microtubule dynamics.

Beghin A, Galmarini CM, Dumontet C.

Curr Cancer Drug Targets. 2007 Dec;7(8):697-703. Review.

PMID:
18220530
20.

ADP ribosylation factor like 2 (Arl2) protein influences microtubule dynamics in breast cancer cells.

Beghin A, Honore S, Messana C, Matera EL, Aim J, Burlinchon S, Braguer D, Dumontet C.

Exp Cell Res. 2007 Feb 1;313(3):473-85. Epub 2006 Oct 28.

PMID:
17188265
21.

A p21/WAF1 mutation favors the appearance of drug resistance to paclitaxel in human noncancerous epithelial mammary cells.

Galmarini CM, Bouchet BP, Audoynaud C, Lamblot C, Falette N, Bertholon J, Wang Q, Beghin A, Dumontet C, Puisieux A.

Int J Cancer. 2006 Jul 1;119(1):60-6.

Supplemental Content

Loading ...
Support Center